Richard Malabre
Comptroller/Controller/Auditor at AKEBIA THERAPEUTICS, INC.
Net worth: 250 824 $ as of 2024-05-30
Richard Malabre active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2024-01-07 | - |
Career history of Richard Malabre
Former positions of Richard Malabre
| Companies | Position | Start | End |
|---|---|---|---|
Ultivue, Inc.
 Ultivue, Inc. BiotechnologyHealth Technology Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 2021-02-28 | 2023-08-31 |
| Treasurer | 2021-02-28 | 2023-08-31 |
Training of Richard Malabre
| Massachusetts Institute of Technology | Graduate Degree |
| Trinity College (Connecticut) | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Comptroller/Controller/Auditor | 1 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Ultivue, Inc.
Ultivue, Inc. BiotechnologyHealth Technology Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Richard Malabre
- Experience
